HBV VIS Detail Information

> This page shows VIS [1009280] detail information, including site information (chromosome, GRCh38 location, disease, sample, etc) and literature information.


Site Information
DVID 1009280
VISID TVIS10020010
Chromosome chr5
GRCh38 Location 37133, 37137
Disease Hepatocellular carcinoma  
Sample Cell line
Virus Reference Genome AF330110
Target Gene TERT     
Literature Information
PubMed PMID 12802289
Published year 2003
Journal Oncogene
Title Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
Author Ferber MJ,Montoya DP,Yu C,Aderca I,McGee A,Thorland EC,Nagorney DM,Gostout BS,Burgart LJ,Boix L,Bruix J,McMahon BJ,Cheung TH,Chung TK,Wong YF,Smith DI,Roberts LR
Evidence HBV and HPV are DNA viruses that almost invariably integrate into the host genome in invasive tumors. The viral integration sites occur throughout the genome, leading to the presumption that there are no preferred sites of integration. A number of viral integrations have been shown to occur within the vicinity of important cancer-related genes. In studies of HBV-induced HCC and HPV-induced CC, we have identified two HBV and three HPV integrations into the human telomerase reverse transcriptase (hTERT) gene. Detailed characterization of the integrations revealed that four integrations occurred within the hTERT promoter and upstream region and the fifth integration occurred in intron 3 of the hTERT gene. None of the integrations altered the hTERT coding sequence and all resulted in juxtaposition of viral enhancers near hTERT, with potential activation of hTERT expression. Our work supports the hypothesis that the sites of oncogenic viral integration are nonrandom and that genes at the sites of viral integration may play important roles in carcinogenesis.

Contents
Description
  • Site Information
Detail information of site [1009280]
  • Literature Information
The details of literature that this site is associated with.